Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab: Predictive Value of Sarcopenia in mRCC. Radiology and Oncology, v. 59, n. 4, p. 624–634, 16 Dec.2025.